Patent lawyers started breathing again Wednesday, as the specter of new patent rules was chased away — at least for a little while — by a Virginia court.

U.S. District Judge James Cacheris granted pharmaceutical giant GlaxoSmithKline’s motion for a preliminary injunction blocking the U.S. Patent and Trademark Office from implementing rules set to go into effect today.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]